15th – 17th April, 2019 | London

Speakers

Expand/Collapse

Alexander Klein
Global Medical Affairs & Digital Health Lead
Roche

Alexander is a passionate healthcare professional with +10 years of international experience in managerial and operational functions in the healthcare industry including pharma, strategy consulting and digital health start-up. In his current role, he leads the development and deployment of the Oncology Digital Health strategy in Global Medical Affairs.  

Day Two

WEDNESDAY, APRIL 17, 2019

13.45 | Advancing Personalised Care & Access Models in Oncology Through Digital Health

Anne-Marie Li-Kwai-Cheung
Project Team Lead for the Multiple Sclerosis (Neuroscience) PHC Showcase
Roche

Anne-Marie is an innovation leader for Roche within the field of neuroscience, leading a team in the development of new digital endpoints, outcomes and tools for the better measurement and management of neurological diseases. For the past 18 years Anne-Marie has been focused on the development of new therapies, primarily for the treatment of neurological disease, working for companies such as Glaxosmithkline, Wyeth, Genzyme, Sanofi.  Working within Roche's personalised health care organisation, Anne-Marie and her colleagues aim to use the new era of digital technology and meaningful data at scale to bring disruptive change to how development is undertaken, and ultimately provide tools for better care of patients, improving their outcomes.

Day One

TUESDAY, 16TH APRIL, 2019

09.45 | Digital technology: Revolutionizing Care from Drug Development to the Clinic

Bert Hartog
Senior Director, Janssen Clinical Innovation
Janssen Pharmaceuticals

Bert is a professional in the pharmaceutical and healthcare industry, with deep expertise in clinical operations and information technology. He holds a Masters Degree in Biomedical Sciences and a PhD in Medicine, and has broad international working experience. He is a strong networker and has learned how to master "managing the matrix". He has a strong track record of developing strategy, delivering outstanding results, implementing transformational change and coaching people for success and personal growth. Bert has worked in management positions in R&D and Clinical Operations, IT, Quality Assurance, and Project Management. He has managed diverse and global teams of up to 100 people and budgets up to 15 Mio USD. He has hands-on experience in operations management, change management, setting strategy, people development, process improvement, development and implementation of an innovation portfolio, and risk management/governance. Bert has an active interest in healthcare innovation, digital health and clinical research and development. He has a relentless focus on continuous improvement and enjoys coaching and managing people for top performance. He is a strong believer in lateral thinking and learning from people in other functions and industries. He is passionate about patient engagement in clinical trials and combining efficient clinical research with social responsibility.

Day One

TUESDAY, 16TH APRIL, 2019

13.45 | Bridging the Gap Between Innovation & Implementation

09.00 | ‘IMPACCT’ Panel Discussion: Driving Digital Transformation & Clinical Innovation in Clinical Research – Bridging the Gap to True Patient- Centricity

Bryan McDowell
Executive Director - Global Program Lead for Data & Digital
Novartis

In his current role as Executive Director - Global Program Lead for Data & Digital, Bryan continues to influence, drive and deliver on the pharma wide industry necessity for smarter, better, faster drug development and clinical trial execution. Beyond his responsibilities to provide leadership for the assessment, testing, and implementation of new technologies and methodologies into clinical trials and programs, Bryan is a thought leader and proponent for initiatives to integrate multiple technologies onto a single platform/device while continuing to push and leverage technologies that not only engage and involve patients in trials but disruptive trial models  also vastly expands the reach and access of trials to more patients while in turn giving more patients access to trials and novel therapies.

Day One

TUESDAY, 16TH APRIL, 2019

09.00 | ‘IMPACCT’ Panel Discussion: Driving Digital Transformation & Clinical Innovation in Clinical Research – Bridging the Gap to True Patient- Centricity

Day Two

WEDNESDAY, APRIL 17, 2019

09.00 | Patient-Focused Drug Development – Building Digital Innovation & Ecosystems in Clinical Research

Caroline Feys
Research & Development Operations Innovation Leader
Janssen Pharmaceuticals

Caroline is currently Innovation Leader at Janssen Pharmaceutica, where she leads transformational innovation projects that have the goal to shape the future of clinical trial execution at Janssen and position Janssen as a role model in patient-centered clinical research. Caroline is a professional in the pharmaceutical industry, with 15 years’ experience in Clinical Operations, Medical Affairs and Medical Program Management. She received her MSc in Biomedical Sciences in 2002 from the Antwerp University and her executive MBA from the Antwerp Management School in 2012.  

Day Two

WEDNESDAY, APRIL 17, 2019

11.00 | Engaging Patient by Providing Access to Patient Data Access In Clinical Trials: From Concept To Implementation

09.30 | ‘IMPACCT’ Panel Discussion: The Patient – Driving Patient Centricity in Clinical Research

Corey Fowler
Associate Director - Global Clinical Development
Otsuka Pharmaceutical Co.

An experienced innovator specializing in digital medicines, Corey has experience in basic, translational, and clinical sciences with a doctorate degree in Pharmaceutical Sciences from the University of North Carolina. Corey has worked in the clinical research industry for more than 10 years with experience in the concept and design, clinical operations, and ethics and regulatory oversight of clinical research studies for phases I-IV.  He now focuses his time on designing and implementing digital medicine strategies at the forefront of pharmaceutical development. Prior to joining Otsuka in 2016, Corey served in Clinical Scientist, Clinical Development, Program Management, Project Management, Business Development and Regulatory Affairs roles spanning industry and academia.  Presently, he serves as Associate Director in Global Clinical Development in CNS and Digital Medicine at Otsuka Pharmaceuticals & Development Corporation.  

Day One

TUESDAY, 16TH APRIL, 2019

12.15 | Building Patient Centricity into Clinical Trials with Digital Medicine & Digital Technologies

David Goren
Independent Consultant, (former- VP of Digital Health Innovation, AstraZeneca)

David is a seasoned pharma executive with extensive experience in strategy, establishing new life science businesses, and most recently specializing in digital health. David has held various senior sales and marketing positions in the pharmaceutical industry since 1991. David is currently a strategy consultant to big pharma and start-ups with a focus in life sciences and digital. He recently left AstraZeneca (after 10 years) as VP Digital Health Strategy. David established AstraZeneca Israel in 2007, and served as Company President until 2014, when he led the global HR Transformation program. Prior to that, in 2011, David led AstraZeneca’s global initiative to revise the policy for ethical interactions with customers and partners. In 1997, David also created Pfizer’s Israel operation and became the CEO and General Manager of Pfizer Israel. David returned to Pfizer US Headquarters in 2004 to lead the Worldwide Strategy and Business Development Group. Prior to being in Israel, David served in various senior sales and marketing roles. David has an MBA from Columbia University, a Bachelors in Biology from Clark University, and has attended Harvard, MIT and INSEAD Executive Management Programs. David has served on various boards including the Raanana Symphonette Orchestra, Kids Kicking Cancer and the Business Ethics Center of Jerusalem.

Florent Schäfer
Clinical Affairs & Human Translational Research, Danone Research
Danone

Florent Schäfer is a Senior Clinical Study Manager at Danone Research & Innovation WWBU. During more than 10 years Florent has been monitoring and managing clinical trials in various indications, in CROs and industry. He currently oversees the operational management of clinical studies evaluating the effect of food on health. As a member of the Healthcare Data Institute, Florent’s work is also focused on the use of novel technologies in nutrition research and on the use of innovative data sources and designs beyond RCT. Florent holds a degree in biochemistry and a MSc specialized in clinical research and medicinal product development from the College of Medicine and Pharmacy of Poitiers.

Day Two

WEDNESDAY, APRIL 17, 2019

14.15 | Advancing Nutrition Research Studies with Novel Technologies

Isabela Niculae
Global Associate Director – Patient Recruitment & Retention Strategist
Biogen

Currently, Isabela Niculae is the Associate Director Patient Feasibility, Enrollment, and Retention Optimization at Biogen responsible for improving the overall patient experiences in clinical trials.  Primary responsibility is to establish global and corporate strategies to help Biogen be the partner of choice for clinical trial patients. Isabela has also held positions as Clinical Program Leader and Clinical Operational Lead working across all phases from preclinical through commercialization and life-cycle management Isabela earned a Bachelor of Arts in Psychology and Cognitive Science from the University of California at San Diego and a Master’s in Public Health from San Diego State University. She also holds a Lean Six Sigma Yellow Belt and is currently co-chair of the UK Women’s Innovation Network at Biogen.

Day Two

WEDNESDAY, APRIL 17, 2019

09.30 | ‘IMPACCT’ Panel Discussion: The Patient – Driving Patient Centricity in Clinical Research

Joss Langford
Chief Technology Officer
Activinsights

Joss Langford is CTO of Activinsights, helping healthcare professionals to collect and analyse lifestyle data to support disease treatment and prevention. He is a founding director of Coelition, an independent non-profit organisation that promotes the responsible use of personal data and open data standards. He has senior management experience in blue chip, SMEs and start-up businesses. Joss holds a BSc in Cybernetics & Control Engineering. He is a Fellow of the RSA and a Member of the IET.

Day One

TUESDAY, 16TH APRIL, 2019

14.45 | Exploring the Role of Behaviour and Lifestyle Insight in Clinical Trials

Jyothis George
Global Head of Diabetes Clinical Development
Boehringer Ingelheim

Jyothis George is a physician-scientist with a decade of clinical research and development of expertise involving over 40,000 patients from more than 40 countries.  He currently leads Boehringer Ingelheim’s clinical development team in CardioMetabolism, which includes two blockbuster drugs.In addition to roles in academia, hospitals and pharmaceutical industry, Dr George has the experience of running a medical informatics company focusing on digital applications in medicine. Tackling inefficiencies in clinical trials using digital and other innovations is therefore a natural interest.  He is a regular contributor to think tanks drawing together thought leaders from academia, industry and regulatory backgrounds.Leveraging this spectrum of experience, Dr Jyothis lead the team to design a lean global clinical trial programme  in chronic kidney disease, with world-leading university partners (Oxford and Duke). This programme incorporates innovative approaches to streamline clinical trial conduct. Within Boehringer Ingelheim, he serves on the global steering committee overseeing the integration of digital tools into medicine.

Day One

TUESDAY, 16TH APRIL, 2019

14.15 | Streamlining Data Collection in Clinical Trials – Case-Studies

09.00 | ‘IMPACCT’ Panel Discussion: Driving Digital Transformation & Clinical Innovation in Clinical Research – Bridging the Gap to True Patient- Centricity

Lisa Shipley
VP, Digital & Analytics Technologies
Merck & Co.

Dr. Shipley is Vice President of Digital and Analytics Technologies in Merck Research Laboratories. She has the overall responsibility to design, operationalize, and direct Discovery, Preclinical and Early Development’s (DPED) contribution to Merck’s digital vision. In partnership with key technical lines, she is responsible for the leadership, operational and strategic management of initiatives focused on advancing knowledge, experience and capabilities in digital technologies, data management and analysis to transform the use of digital health approaches in all stages of drug discovery and clinical trial management, moving from a site-centric to patient centric model of drug development.  

Day One

TUESDAY, 16TH APRIL, 2019

11.45 | Sampling Approaches in Patient-Centric Trials

Manuela Schöner
Corporate Strategy & Consulting
Boehringer Ingelheim

Manuela is a quantitative economist and data scientist with excellent strategic thinking skills. She holds a triple degree in Finance & Economics allied with 8 years of professional experience in strategic consulting & data analytics with focus on pharmaceutical markets. Manuela is prepared to present insights to a broad audience, to influence senior leaders across functions and challenge them in a collaborative and constructive way. Manuela is passionate about emerging technologies in the pharmaceutical arena. She participated in the first “Health meets Blockchain” hackathon in Heidelberg, Germany, and advised a team of students and young professionals which won the first prize for their prototype LifeCrypter. She has published papers together with leading experts in the Blockchain area and is regularly invited as guest speaker to international conferences.

Michaela Kazmaier
IT Benefits Realisation Manager
Dimension Data

Michaela Kazmaier is a financial economist with 10 years of professional experience in Financial Services, Information Technology and Corporate Finance Advisory. Michaela believes in a significant disruption of classical business models as well as Alternative Financing structures due to emerging technologies. She is passionate about identifying and developing those opportunities. Michaela advised India’s largest Initial Coin Offering that raised 40 Mio. USD and implemented a blockchain solution in retail business. She also defined a Blockchain Identity Management use case for a top tier bank based in Mumbai. Michaela holds a Master of Finance in Capital Markets from Frankfurt School, BBA in International Business from ESB Reutlingen, B.A. in Business Management with Distinction from Napier University Business School, was awarded with a degree medal and was sponsored with a Leadership Program at IE Business School.

Sam Hariry
Head of Clinical Strategy & Operations
Novartis Institutes for Biomedical Research (NIBR)

Sam is a group manager and strategic leader with over 15 years of experience in the pharmaceutical industry. He currently serves as the Head of Clinical Strategy and Operations at Novartis Institutes for Biomedical Research (NIBR). Sam has strong experience in early phase drug development, and profiling development to support drug registrations. In his current role, Sam is responsible for global leadership of clinical study operational strategy across all therapeutic areas for the Translational Medicine department, within NIBR. He is also a chair for Clinical Operational Board to review NIBR clinical trials with respect to design, execution strategy, feasibility, resources and budget. He oversees continuous learning on study design and new innovative approaches for the conduct of clinical trials. Sam has hold several previous roles at Novartis for the past 14 years, as well as GSK and Covance, before that. He holds a MSc. in Clinical Research from Cardiff University, and BSc. in Biomedical Sciences from the University of Southampton.

Day One

TUESDAY, 16TH APRIL, 2019

11.15 | Patient-Centric Trials – What’s next?

Sheli Gupta
President, European Operations
Hu-manity.co

Shaleen (Sheli) Gupta has recently relocated to the UK from NJ, USA to establish and run the European operations of Hu-manity.co (https://hu-manity.co/), the company championing the 31st Human Right for individuals to own their data as property. Sheli is a serial entrepreneur with a passion for taking ideas and bringing them to life, with a focus on software.  He began his entrepreneurial journey at the tender age of 7 learning the whole lifecycle of door hinge manufacturing in the family business in Nairobi, Kenya, followed by selling school punishment lines at boarding school in the UK, and ultimately starting, growing and selling a number of software companies in the USA. To date, his most successful venture has been Software Associates International (SAI), which Sheli co-founded in 1994 as a 2 person basement-based consulting firm growing it to a highly successful 180 person sales and marketing software company servicing the US Pharmaceutical Industry, including major clients such as Johnson & Johnson, Abbott Labs, and Eli Lilly.  SAI & Sheli won numerous awards, including Ernst & Young’s Entrepreneur of the Year in New Jersey, and several Deloitte & Touche Awards.  SAI was acquired by a global CRM company. Sheli was born in Nairobi, Kenya and has travelled extensively as a result of his passion for travel and exploring new cultures.  He enjoys golf, is fluent in English & Punjabi, and a little rusty in French, Spanish & Swahili!  He completed his secondary education as a boarding student at Kimbolton School, Cambridgeshire UK, followed by his B.Sc. in Computer & Electronic Engineering at King’s College, University of London.  He is now based in Kimbolton, England.

Day Two

WEDNESDAY, APRIL 17, 2019

11.30 | Your Data, Your Property – Delving into Patient Data Ownership

09.30 | ‘IMPACCT’ Panel Discussion: The Patient – Driving Patient Centricity in Clinical Research

Theodoros Arvanitis
Professor of e-Health Innovation & Head of Research - Institute of Digital Healthcare (IDH)
University of Warwick

Theodoros N. Arvanitis is a Professor of e-Health Innovation and Head of Research at The Institute of Digital Healthcare, WMG, at University of Warwick. He is also an Affiliate Professor at Warwick Medical School and Honorary Professor at the Institute of Cancer and Genomic Sciences, University of Birmingham. He has recently taken the post of Associate Director, Midlands Site, HDR UK. Within WMG, he leads the Biomedical Informatics, Imaging and Healthcare Technologies Research Group. He received his RT (BSc) degree (medical radiological technology) in 1990, from the Technological Educational Institute of Athens, Greece, and his DPhil (biomedical engineering) in 1997 from the University of Sussex, UK. Prior to joining the University of Warwick in 2013, he held various posts at the University of Sussex and the University of Birmingham. His postdoctoral work at the University of Sussex included a lab director/research fellow post at the Trafford Centre for Medical Research (1995) and a full-time lectureship in the School of Cognitive and Computer Sciences (1995-1998). In 1998, he joined the School of Electronic, Electrical & Computer Engineering, University of Birmingham, UK, as a full-time Lecturer (1998-2003), Senior Lecturer (2003-2007) and subsequently Reader in Biomedical Informatics, Signals and Systems (2007-2013). He has held the post of co-Director of the West Midlands Academic Health Science Network (WM AHSN) Digital Theme (2014-2016). His research interests span the areas of biomedical engineering, neuroimaging and health informatics. Professor Arvanitis has a substantial academic publication record, while he has received research funding from national (UK), European and international governmental funding agencies, charities and industry. Theo has been involved in UK (BSI) and EU (CEN) standardisation work. He is a Charted Engineer (CEng), Fellow of the Royal Society of Medicine (FRSM and a member of various scientific and professional groups (IET, AMIA, NYAS, RCS, ISMRM). He is also the Joint Editor-in-Chief at the Digital Health, open access peer-reviewed, journal, published by Sage Publications, UK.

Day One

TUESDAY, 16TH APRIL, 2019

15.25 | Accelerating Patient Recruitment & Managing Clinical Data with Digital Tools

Tom Denwood
Executive Director of Data, Insights & Statistics
NHS Digital

Tom passionately believes that putting people in control of their care, through tech, will enhance their lives and those of their families and carers. Toms team collects, holds in trust, and makes available the nation’s health and care data. He is a change agent on the Mayor of London’s Congestion Charging Scheme, NHS National Programme for IT, and Security for London 2012. Tom has a MSc Major Programme Management (Oxford), is a graduate of HM Government’s Major Projects Leadership Academy, and is a Fellow of the BCS.

Day One

TUESDAY, 16TH APRIL, 2019

15.55 | Enabling World-Class Clinical Trials Using National NHS Data